Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Collegium Pharmaceutical (COLL) Current Assets (2016 - 2025)

Historic Current Assets for Collegium Pharmaceutical (COLL) over the last 10 years, with Q3 2025 value amounting to $613.9 million.

  • Collegium Pharmaceutical's Current Assets rose 3831.82% to $613.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $613.9 million, marking a year-over-year increase of 3831.82%. This contributed to the annual value of $482.3 million for FY2024, which is 1029.45% down from last year.
  • Latest data reveals that Collegium Pharmaceutical reported Current Assets of $613.9 million as of Q3 2025, which was up 3831.82% from $549.2 million recorded in Q2 2025.
  • Collegium Pharmaceutical's 5-year Current Assets high stood at $613.9 million for Q3 2025, and its period low was $296.3 million during Q1 2021.
  • Moreover, its 5-year median value for Current Assets was $482.3 million (2024), whereas its average is $456.2 million.
  • Per our database at Business Quant, Collegium Pharmaceutical's Current Assets skyrocketed by 3857.06% in 2021 and then plummeted by 1736.71% in 2024.
  • Over the past 5 years, Collegium Pharmaceutical's Current Assets (Quarter) stood at $315.5 million in 2021, then soared by 33.1% to $420.0 million in 2022, then increased by 28.0% to $537.6 million in 2023, then fell by 10.29% to $482.3 million in 2024, then grew by 27.29% to $613.9 million in 2025.
  • Its Current Assets stands at $613.9 million for Q3 2025, versus $549.2 million for Q2 2025 and $527.6 million for Q1 2025.